Robbins LLP logo white Background.png
BNTX INVESTOR NEWS: Shareholders Should Contact Robbins LLP for Information About the Securities Fraud Class Action Against BioNTech SE
February 06, 2024 00:36 ET | Robbins LLP
BioNTech SE (BNTX) Allegedly Misled Investors Regarding its Business Prospects
Robbins LLP logo white Background.png
EVVTY Class Action Alert: Robbins LLP Reminds Investors of Evolution AB (publ) Class Action
February 01, 2024 17:50 ET | Robbins LLP
Evolution AB (EVVTY) Misled Investors Regarding its Business Prospects
Robbins LLP logo white Background.png
AlloVir, Inc. (ALVR) Stockholder News: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in AlloVir, Inc. Class Action
January 29, 2024 19:45 ET | Robbins LLP
AlloVir, Inc. (ALVR) Allegedly Misled Investors Regarding Efficacy of its posoleucel Phase 3 Studies
Robbins LLP logo white Background.png
BioVie Inc. (BIVI) Stockholder News: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in BioVie Inc. Class Action
January 29, 2024 19:27 ET | Robbins LLP
BioVie Inc. (BIVI) Allegedly Failed to Disclose Scientific Misconduct in Connection with its Clinical Trial
Robbins LLP logo white Background.png
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Evolution AB (publ) (EVVTY)
January 24, 2024 20:25 ET | Robbins LLP
Evolution AB (EVVTY) Misled Investors Regarding its Business Prospects
Robbins LLP logo white Background.png
ASRT Class Action Alert: Stockholders with Significant Losses in Assertion Holdings, Inc. Should Contact Robbins LLP for Information About the Class Action Lawsuit Against the Company
January 24, 2024 20:23 ET | Robbins LLP
Assertio Holdings, Inc. (ASRT) Allegedly Misled Investors Regarding its Reliance on Indocin and Integration of Spectrum Pharmaceuticals, Inc.
Robbins LLP logo white Background.png
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against BioVie Inc. (BIVI)  
January 23, 2024 15:24 ET | Robbins LLP
BioVie Inc. (BIVI) Allegedly Failed to Disclose Scientific Misconduct in Connection with its Clinical Trial
Robbins LLP logo white Background.png
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against AlloVir, Inc. (ALVR)
January 22, 2024 21:09 ET | Robbins LLP
AlloVir, Inc. (ALVR) Allegedly Misled Investors Regarding Efficacy of its posoleucel Phase 3 Studies
Robbins LLP logo white Background.png
Dada Nexus Limited (DADA) Investor Alert: Robbins LLP Reminds Shareholders of Class Action Against Dada Nexus Limited
January 22, 2024 17:59 ET | Robbins LLP
Dada Nexus Limited (DADA) Allegedly Overstated its Revenues
Robbins LLP logo white Background.png
Robbins LLP Reminds Fisker Inc. Investors of Pending Lead Plaintiff Deadline in FSR Class Action
January 10, 2024 14:12 ET | Robbins LLP
Fisker Inc. (FSR) Failed to Disclose a Material Weakness in Internal Control Over Financial Reporting